Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$504,247
+$349,416 QoQ
Shares Held
278,590
+142.9% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jain Global LLC holds $54,003,993 across 44 Biotechnology names. OCGN ranks #17 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
47,962 | $15,869,186 | |
| 2 | ASND |
Ascendis Pharma A/S
|
17,207 | $3,935,757 | |
| 3 | ARGX |
Argenx SE
|
4,641 | $3,389,090 | |
| 4 | RPRX |
Royalty Pharma plc
|
66,353 | $3,182,953 | |
| 5 | MRNA |
Moderna, Inc.
|
62,646 | $3,182,416 | |
| 6 | NKTR |
Nektar Therapeutics
|
36,181 | $2,603,222 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
85,178 | $2,359,430 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,677 | $2,088,467 |
All Filings in OCGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $504,247 | 278,590 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $154,831 | 114,690 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $174,416 | 107,004 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $407,418 | 420,019 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||